Venice Summer School 2009: Programme
The five-day course will develop a better understanding of the challenges in stimulating and assessing innovation in health-care provision and will explore ways of organizing effective evaluations, designing related decision-making processes and setting up relevant institutions. It will be organized into three modules:
MODULE 1: INNOVATION
The first module will look at the different dimensions of innovation, not only in medical products and health care interventions but also in broader health-system organization. Also based on experience from other economic sectors, it will explore what challenges innovation represents for the organisation of health systems and how it can be steered towards meeting the values and goals that governments have set for their health systems.
Issues that will be addressed in this module include:
- Defining concepts: innovation, health technology, HTA, quality in health care, etc…;
- Expectations and values related to innovation;
- Drivers and stumbling blocks for innovation;
- Diffusion and management of innovation;
- Innovation in processes and services;
- A policy framework for innovation.
MODULE 2: EVALUATION
In this module we will explore the experience of evaluating three different types of health technologies: (1) medical products and services (i.e. “health technologies” in a narrow sense), (2) regulatory and policy measures and (3) public health interventions. It will look at different models and methods for HTA, how evidence is used and how HTA and innovation contribute to quality improvement strategies.
Lectures and discussions in this module will cover following aspects:
- Assessing different types of medical products and services (drugs, diagnostics, devices, procedures and e-health applications): selection, assessment processes and methodologies;
- Policy measures (regulatory approval, reimbursement systems, national guidance or clinical guidelines) and public health interventions: similarities and peculiarities compared to assessing medical products and services;
- Differences between context-free (internationally applicable) and context-dependent (national/local) evidence;
- Integration of scientific and "colloquial" evidence.
MODULE 3: TRANSLATION
This last module will focus on the translation of evidence and assessment outcomes into policies and clinical practices. Starting from analysing the impact and effect of HTA reports and guidelines, it will address the key question “what are effective ways of knowledge translation and brokering in health policy and health care practice”.
These are some of the elements that will be tackled in this part:
- Needs and demands of policy makers and practitioners;
- Design of effective assessment institutions and decision-making processes;
- The role of the EU, WHO and other international organisations;
- The role of stakeholders, including consumer organisations, professional organisations and the industry;
- Information and communication.